Endoscopic sclerotherapy and banding ligation are the two preferred methods to treat oesophageal variceal bleeding. There are many reports dealing with such treatment in cirrhotic patients but we do not know how good they are to treat varices secondary to other forms of portal hypertension. Schistosomiais mansoni is the main cause of portal hypertension and oesophageal varices in Brazil. We performed a prospective randomised study to compare: 1) the efficacy of both treatments in eradicating oesophageal varices, and 2) complications secondary to both treatments. Forty patients were divided in two Groups. Both sclerotherapy and banding ligation were performed until variceal eradication. There were no severe complications. Variceal eradication was faster obtained with banding ligation than sclerotherapy although there was no statistical difference (mean number of sessions 3.05 vs 3.72, p=0.053). Benign complications were equally frequent in both Groups, although additional sedation was more common in the sclerotherapy Group. We concluded that both treatments are equally effective in the eradication of oesophageal varices, although banding ligation is better tolerated by the patient and probably faster.
INTRODUCTION
Upper gastrointestinal haemorrhage (UGH) secondary to oesophageal varices (EV) rupture is a severe clinical complication of portal hypertension (PH) [1] . It occurs in approximately 30% of patients with hepatic cirrhosis and EV [2, 3] . First episode mortality rate is high, up to 50% of patients [3, 4] . Re-bleeding in non treated patients occurs in 47% to 84% of cases and the correspondent mortality rate ranges from 20% to 70% [5, 61. Sclerotherapy (ST) and band ligation (BL) are the two most widely used endoscopic procedures in the treatment of EV [7] .
Endoscopic sclerotherapy shows up to 95% efficacy in the treatment of a severe variceal bleeding episode [5, 8] . Endoscopic treatment should be the choice for re-bleeding prophylaxis, if liver transplantation is not available. ST should be considered as prophylaxis for the first variceal bleeding episode in patients with high *Author for correspondence: Dr. Angelo P. Ferrari [4, 7] . However, there is a high incidence of complications that may reach 70% of procedures [9] .
By eliminating sclerosant solutions, endoscopic banding ligation has reduced the complication rate associated with EV endoscopic treatment [10] [11] [12] . Several prospective studies have proven the efficacy of such procedure in the treatment of EV bleeding [13, 14] .
Most [18] . A number of studies have proven the efficacy of ST and surgical procedures (shunts and devascularization) in preventing re-bleeding in such patients [19] [20] [21] . The few studies using primary prophylaxis were not conclusive [15, 16] Although surgical treatment is largely used in HSS patients with bleeding EV [15, 21, 26, 27] , endoscopic treatment can also be successfully used [19, 20, 28] The average number of ST sessions required to eradication (3, 72) was similar to the published data, both for cirrhosis and.schistosomiasis, although only patients with medium and large size varices were enrolled in this study [13, 14, 19] . No EV bleeding was noted eradication. Variceal recurrence after sclerotherapy treatment reaches upto 40% in the first year following treatment [1, 19, 29] . Our recurrence rate after 6 months was 5%.
Incidence of post ST complications was also similar to those reported in the literature [14, 19] 
